Telix Q1 2024 Revenue and Business Update
Filed with ASX · · 3 pages · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallTelix Pharmaceuticals Limited on 6ix
Story so far
Earlier from Telix Pharmaceuticals
- TLX101-CDx (Pixclara) Granted FDA Fast Track Designation
- Telix Completes Acquisition of ARTMS
- Telix Completes Acquisition of IsoTherapeutics
- Telix General Meeting Presentation
- Telix General Meeting Chairman and CEO Addresses
Later from Telix Pharmaceuticals
- Telix Completes Acquisition of QSAM
- Telix Reports Q1 2024 Financial Performance
- Telix has Filed Registration Statement for Proposed US IPO
- Telix Completes Proof-of-Concept Study for Alpha Therapy
- Telix Annual General Meeting - Chairman and CEO Addresses
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals